skip to main content
Show only
Refined by: resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Research from Institute for Atmospheric and Climate Science Provides New Data on Climate Change (CH2018 - National climate scenarios for Switzerland: How to construct consistent multi-model projections from ensembles of opportunity) (CH2018 - ...)
Material Type:
Newsletter Articles
Add to e-Shelf
2
Patent Issued for Immunomodulatory Oligonucleotides
Material Type:
Newsletter Articles
Add to e-Shelf

Patent Issued for Immunomodulatory Oligonucleotides

Biotech Week, 2012, p.924

NewsRX LLC

Full text available

3
University of Iowa Research Foundation; Patent Issued for Immunomodulatory Oligonucleotides
Material Type:
Newsletter Articles
Add to e-Shelf

University of Iowa Research Foundation; Patent Issued for Immunomodulatory Oligonucleotides

Biotech Week, 2012, p.924

Atlanta: NewsRx

Full text available

4
Patent Application Titled "Method and Compositions for Treatment Or Prevention of Inflammatory Conditions" Published Online (USPTO 20160256444)
Material Type:
Newsletter Articles
Add to e-Shelf

Patent Application Titled "Method and Compositions for Treatment Or Prevention of Inflammatory Conditions" Published Online (USPTO 20160256444)

Biotech Week, 2016, p.386

NewsRX LLC

Full text available

5
Patent Issued for Aggregation and Workflow Engines for Managing Project Information
Material Type:
Newsletter Articles
Add to e-Shelf

Patent Issued for Aggregation and Workflow Engines for Managing Project Information

Journal of Engineering, 2016, p.1496

NewsRX LLC

Full text available

6
Life Science Research - Digestion Research; Findings from Georg-August-University Update Knowledge of Digestion Research (Testing Ofhelicobacter Pyloriby Endoscopic Biopsy: the Clinical Dilemma of Suppressive Conditions)
Material Type:
Newsletter Articles
Add to e-Shelf
7
AtheroGenics Announces Three Abstracts to Be Presented at ATS 2003; Preclinical Studies Evaluate Novel Second Generation V-Protectants in Asthma
Material Type:
Newsletter Articles
Add to e-Shelf

AtheroGenics Announces Three Abstracts to Be Presented at ATS 2003; Preclinical Studies Evaluate Novel Second Generation V-Protectants in Asthma

PR Newswire, 2003, p.1

New York: PR Newswire Association LLC

No full-text

8
Recent Findings from Swiss Federal Institute of Technology Zurich
Material Type:
Newsletter Articles
Add to e-Shelf

Recent Findings from Swiss Federal Institute of Technology Zurich

Science Letter, 2021, p.1228-1228

NewsRX LLC

Full text available

9
AtheroGenics Announces Promotion of Charles Kunsch, Ph.D. to Director Of Biological Research
Material Type:
Newsletter Articles
Add to e-Shelf

AtheroGenics Announces Promotion of Charles Kunsch, Ph.D. to Director Of Biological Research

PR Newswire, 2000, p.1

New York: PR Newswire Association LLC

No full-text

10
Olympus ENDOCUFF Now FDA 510(k)-Cleared to Claim Improvement in Adenoma Detection Rate during Colonoscopy: In Screening and Surveillance, ENDOCUFF Provides Improvement in Detection of Pre-Cancerous Polyps during Colonoscopy - Reducing Risk of "Missed" Cancer
Material Type:
Newsletter Articles
Add to e-Shelf

Olympus ENDOCUFF Now FDA 510(k)-Cleared to Claim Improvement in Adenoma Detection Rate during Colonoscopy: In Screening and Surveillance, ENDOCUFF Provides Improvement in Detection of Pre-Cancerous Polyps during Colonoscopy - Reducing Risk of "Missed" Cancer

PR Newswire, 2016

New York: PR Newswire Association LLC

No full-text

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Full Text Online (12)

Creation Date 

From To
  1. Before2000  (1)
  2. 2000To2002  (1)
  3. 2003To2011  (1)
  4. 2012To2016  (7)
  5. After 2016  (6)
  6. More options open sub menu

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far